alpha-amanitin and Peritoneal Carcinomatosis

alpha-amanitin has been researched along with Peritoneal Carcinomatosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Endo, F; Ikeda, M; Ishida, K; Ito, C; Ito, K; Iwaya, T; Katagiri, H; Kume, K; Miura, S; Nishizuka, SS; Ohmori, Y; Sato, KA	1

Other Studies

1 other study(ies) available for alpha-amanitin and Peritoneal Carcinomatosis

Article	Year
α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15. Scientific reports, 2016, 05-16, Volume: 6 Topics: Alpha-Amanitin; Animals; Cell Line, Tumor; Cisplatin; Down-Regulation; Drug Resistance; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; HCT116 Cells; HeLa Cells; HT29 Cells; Humans; MCF-7 Cells; Mice; Peritoneal Neoplasms; Proteomics; Secondary Prevention; TATA-Binding Protein Associated Factors; Transcription, Genetic; Xenograft Model Antitumor Assays	2016

Article

Year

α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15.

Scientific reports, 2016, 05-16, Volume: 6

Topics: Alpha-Amanitin; Animals; Cell Line, Tumor; Cisplatin; Down-Regulation; Drug Resistance; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; HCT116 Cells; HeLa Cells; HT29 Cells; Humans; MCF-7 Cells; Mice; Peritoneal Neoplasms; Proteomics; Secondary Prevention; TATA-Binding Protein Associated Factors; Transcription, Genetic; Xenograft Model Antitumor Assays

2016